24.09.2026 aktualisiert


100 % verfügbar
Ex-Bain I AI, Strategy & Transformation Consultant | Life Sciences, Healthcare and Digital Health
München, Deutschland
Deutschland +2
Dr. rer. nat. Neuroscience, University of Leipzig & Max-Planck-Institute Goettingeninfo: Deutschland, Österreich, Schweiz
Über mich
Ex-Bain consultant, PhD and biotech founder, with deep expertise in life sciences. I deliver transformation, portfolio and market entry projects and identify AI use cases that create measurable value, with a structured, scalable pilot built for adoption, and lead them through to implementation
Skills
AI AgentsOKRUnternehmensberatungAusführende FunktionenPortfolio-OptimierungStrategieausführungExecutive ManagementProjektlieferung
Ex-Bain I Strategy & Operations Consultant | Life Sciences, Pharma, Biotech, Digital Health | PhD Neuroscience (Max Planck) I AI use cases from business case to scalable pilot
TRACK RECORD
- Delivered operational efficiency and effectiveness gains across the Technical Operations division of an international pharma company, leading a 9-month transformation program as project lead across 15+ teams (e.g., created ownership of supply chain management, standardized MSW, SOW, cut meeting load by >20%)
- Developed a global supply network resilience strategy for a biotech, establishing cross-functional supplier governance with harmonized risk criteria and standardized MSA/SOW templates, and identifying ~USD 15M in consolidation potential
- Realized >€10M savings within 6 months through a cost transformation across two European chemical production sites (Bain & Company)
- Held full P&L responsibility (>€3M) for a flagship digital therapeutic, growing revenue and market share and leading a clinical trial for EU reimbursement
- Designed the German hospital market entry strategy for an international generics manufacturer, with portfolio focus, resource allocation and five-year roadmap
- Developed a portfolio optimization strategy with implementation roadmap for a top-20 pharma company
FUNCTIONAL EXPERTISE
- Design and run transformation and change programs, from operating model, RACI and process harmonization through PMO, governance and steering committees to cost transformation and operational excellence, leading cross-functional teams and C-level stakeholders
- Build the commercial case behind decisions through portfolio strategy, business cases, due diligence, market entry and full P&L management
- Identify and implement AI use cases for life sciences clients, from screening R&D, technical operations and commercial processes for measurable value, through the business case, to a structured, scalable pilot built for adoption and full implementation
- Cover the pharma and biotech specifics, from commercialization and supply chain resilience with supplier risk and contract management to clinical operations and strategy in GxP environments, and facilitate the actions that turn analysis into decisions
TOOLS & TECHNICAL SKILLS
- Analytics & modelling: Advanced Excel (financial models, valuations, scenario and sensitivity analysis, KPI dashboards, steering cockpits)
- AI-accelerated delivery: task-specific agents and analytical workflows built in Claude Code, Gemini or ChatGPT (research, market sizing, benchmarking, competitive intelligence, M&A screening, KPI dashboards, memo drafting). Compresses research and analysis from days to hours, draws on a broader set of sources, with human validation of source quality
- Platforms: Jira, Confluence, Miro, Microsoft Office Suite
Erfahrung
Berufserfahrung5 - 10 Jahre
Freelancer seit2026
Sprachen
DeutschMutterspracheEnglischverhandlungssicher
Projekthistorie
Strategy and management consulting in life sciences, pharma, and biotech. Delivered measurable efficiency gains within an international Technical Operations Division transformation program, managing 15+ client teams across 2 continents for a pharmaceutical company. Developed resilience strategy and implementation roadmap for the global supply network of a biotech company. Developed the German hospital market entry strategy for an international generics manufacturer.
Digital health with full P&L responsibility and clinical operations. Held full P&L responsibility (>3M EUR) for the flagship digital therapy Kranus Edera, achieving sustainable revenue and market share growth. Streamlined decision-making and enhanced interdisciplinary collaboration. Planned, initiated, and led a national monocentric clinical trial to secure regulatory reimbursement in an additional EU5 country.